Don't miss this exciting event when world renowned experts in
solid organ
transplantation will critically analyze old and new data and participate in provocative discussions about this difficult issue. The program offers ample opportunity for audience participation including question and answer periods, interaction using an audience response system, and the opportunity to engage in stimulating discussions.
Following the scientific sessions, join us for dinner and networking with fellow transplant professionals.
Attendees will receive a printed course syllabus upon arrival. On the following day, attendees can pick up an electronic copy of this symposium at the AST membership booth.
AST gratefully acknowledges the support of
this continuing medical education activity by Wyeth Pharmaceuticals.
Scientific
Program Chronic Allograft Nephropathy: The Tough Questions Remain
Moderator:
Philip F. Halloran, MD, PhD
University of Alberta
6:30 PM 7:00 PM
Arrivals and Reception
7:00 PM 7:10 PM
Welcome Remarks Philip F. Halloran, MD, PhD
University of Alberta
7:10 PM 7:30 PM
Chronic Allograft Nephropathy: Is This Really a Pathological Entity or
General Consequence of Injury? Robert B. Colvin, MD
Harvard Medical School
7:30 PM 7:40 PM
Questions and Answers
7:40 PM 8:00 PM
Is Chronic Allograft Nephropathy Changing
as We Change Our Drugs: What Do Studies Tell Us? Herwig-Ulf Meier-Kriesche, MD
SHANDS at the University of Florida
8:00 PM 8:10 PM
Questions and Answers
8:10 PM 8:30 PM
What Can We Do About This Injury? Immunosuppressants and Their Role in Chronic Allograft
Nephropathy Bryan N. Becker, MD
University of Wisconsin , Madison
8:30 PM 8:40PM
Questions and Answers
8:40 PM 9:00 PM
Altering Drug Therapies in Failing Kidneys: When is It Too Late to Change? Jeremy R. Chapman, MD
The University of Sydney
9:00 PM 9:10 PM
Questions and Answers
9:10 PM 9:30 PM
Questions and Answers with Panel and
Closing Remarks Moderator: Philip F. Halloran, MD, PhD
Panel: All Faculty
At the completion of this symposium,
attendees will be able to:
Critically analyze the extent that the diagnosis
of chronic allograft nephropathy is problematic.
Explain the pathobiology of chronic allograft
nephropathy.
Describe what can be done to alter the rate
of decline in renal function.
Interpret the current studies and registry
data that examine changes in kidney transplant.
Critically analyze current strategies used
to manage recipients of kidney grafts with a diagnosis of chronic
allograft nephropathy.
Evaluate whether or not timing and drug interventions
can alter the outcomes of transplant recipients prior to or with
established chronic allograft nephropathy.
Accreditation
Physicians
The American Society of Transplantation (AST) is accredited by the
Accreditation Council for Continuing Medical Education to provide
continuing medical education for physicians.
AMA PRA Statement
AST designates this educational activity for a maximum of 2.5 AMA
PRA Category 1 Credit(s)™. Physicians should only claim
credit commensurate with the extent of their participation in the
activity.
Satisfactory completion: Participants must complete
an attendance/evaluation form in order to receive a certificate
of completion/attendance. Certificates will be sent 3-4 weeks after
the seminar.
Nurses
This course is co-provided by Amedco and The American Society of
Transplantation. Amedco, St Paul, MN, is an approved provider of
nursing continuing education by the Wisconsin Nurses Association
Continuing Education Approval Program Committee, an accredited approver
by the American Nurses Credentialing Center's Commission on Accreditation.
3.0 contact hours. CA: Amedco approved by the CA Board of Registered
Nursing, Provider #CEP13683, for 3.0 contact hours.
Transplant Coordinators
Category 1 Continuing Education Points for Transplant Coordinators
(CEPTCs) have been applied for through the American Board for Transplant
Certification (ABTC).
Pharmacists
Amedco, LLC is accredited
by the Accreditation Council for Pharmacy Education as a provider
of continuing pharmacy education. Successful completion of this
program qualifies for up to 2.5 contact hours. Initial release
date: July 25, 2006. UPN: 453-999-06-005-L04.
ADA Statement: ADA accommodations
will be made in accordance with the law. If you require ADA accommodations,
please indicate what your needs are at the time of registration.
We cannot ensure the availability of appropriate accommodations
without prior notification.